Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David M Berman

Showing results (101-110 of 121) with videos related to

Pageof 13
Sort By:
Nature Genetics|January 11, 2007
A stem cell-like chromatin pattern may predispose tumor suppressor genes to DNA hypermethylation and heritable silencingJoyce E Ohm, Kelly M McGarvey, Xiaobing Yu, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 29, 2012
Secreted protein, acidic and rich in cysteine-like 1 (SPARCL1) is down regulated in aggressive prostate cancers and is prognostic for poor clinical outcomePaula J Hurley, Luigi Marchionni, Brian W Simons, et al.
Plos One|August 2, 2014
Identification of ALK gene alterations in urothelial carcinomaJoaquim Bellmunt, Shamini Selvarajah, Scott Rodig, et al.
Cell Communication and Signaling : CCS|September 19, 2019
Abi1 loss drives prostate tumorigenesis through activation of EMT and non-canonical WNT signalingDisharee Nath, Xiang Li, Claudia Mondragon, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 21, 2005
Tumor progression can occur despite the induction of very high levels of self/tumor antigen-specific CD8+ T cells in patients with melanomaSteven A Rosenberg, Richard M Sherry, Kathleen E Morton, et al.
Cancer Medicine|February 28, 2015
HER2 as a target in invasive urothelial carcinomaJoaquim Bellmunt, Lillian Werner, Aristotle Bamias, et al.
Cancer Research|September 16, 2010
Cancer-related epigenome changes associated with reprogramming to induced pluripotent stem cellsJoyce E Ohm, Prashant Mali, Leander Van Neste, et al.
Cancer Medicine|May 22, 2014
FGFR3 expression in primary and metastatic urothelial carcinoma of the bladderElizabeth A Guancial, Lillian Werner, Joaquim Bellmunt, et al.
Journal of the National Cancer Institute|March 5, 2020
Risk Stratification of Prostate Cancer Through Quantitative Assessment of PTEN Loss (qPTEN)Tamara Jamaspishvili, Palak G Patel, Yi Niu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 4, 2015
Development and clinical validation of an in situ biopsy-based multimarker assay for risk stratification in prostate cancerPeter Blume-Jensen, David M Berman, David L Rimm, et al.
Pageof 13

Showing results (101-110 of 121) with videos related to

Sort By:
Pageof 13
Nature Genetics|January 11, 2007
A stem cell-like chromatin pattern may predispose tumor suppressor genes to DNA hypermethylation and heritable silencingJoyce E Ohm, Kelly M McGarvey, Xiaobing Yu, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 29, 2012
Secreted protein, acidic and rich in cysteine-like 1 (SPARCL1) is down regulated in aggressive prostate cancers and is prognostic for poor clinical outcomePaula J Hurley, Luigi Marchionni, Brian W Simons, et al.
Plos One|August 2, 2014
Identification of ALK gene alterations in urothelial carcinomaJoaquim Bellmunt, Shamini Selvarajah, Scott Rodig, et al.
Cell Communication and Signaling : CCS|September 19, 2019
Abi1 loss drives prostate tumorigenesis through activation of EMT and non-canonical WNT signalingDisharee Nath, Xiang Li, Claudia Mondragon, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 21, 2005
Tumor progression can occur despite the induction of very high levels of self/tumor antigen-specific CD8+ T cells in patients with melanomaSteven A Rosenberg, Richard M Sherry, Kathleen E Morton, et al.
Cancer Medicine|February 28, 2015
HER2 as a target in invasive urothelial carcinomaJoaquim Bellmunt, Lillian Werner, Aristotle Bamias, et al.
Cancer Research|September 16, 2010
Cancer-related epigenome changes associated with reprogramming to induced pluripotent stem cellsJoyce E Ohm, Prashant Mali, Leander Van Neste, et al.
Cancer Medicine|May 22, 2014
FGFR3 expression in primary and metastatic urothelial carcinoma of the bladderElizabeth A Guancial, Lillian Werner, Joaquim Bellmunt, et al.
Journal of the National Cancer Institute|March 5, 2020
Risk Stratification of Prostate Cancer Through Quantitative Assessment of PTEN Loss (qPTEN)Tamara Jamaspishvili, Palak G Patel, Yi Niu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 4, 2015
Development and clinical validation of an in situ biopsy-based multimarker assay for risk stratification in prostate cancerPeter Blume-Jensen, David M Berman, David L Rimm, et al.
Pageof 13